发明名称 3-(INDOL-1-YL)-4-(INDOL-3-YL)-PYRROLE-2,5-DIONES,3-(BENZIMIDAZOL-1-YL)-4-(INDOL-3-YL)-PYRROLE-2,5-DIONES, AND 3-(INDOLIN-1-YL)-4-(INDOL-3-YL)-PYRROLE-2,5-DIONES; THEIR PREPARATION AND USE AS MODULATORS OF APOPTOSIS
摘要 This invention features compounds of formula (I), (II) and (III), which are useful in the treatment of proliferative disorders characterized by loss of growth or cellular differentiation control including, but not limited to, cancer and inflammation. Formulas (I), (II), (III) have functional groups designated as A<1>, A<2>, B<1>, B<2>, X<1>-X<9> and R<l >-R<8> as defined further.
申请公布号 WO2005014584(A8) 申请公布日期 2005.09.09
申请号 WO2004CA01484 申请日期 2004.08.11
申请人 AEGERA THERAPEUTICS INC.;JAQUITH, JAMES, B.;GILLARD, JOHN, W.;LAURENT, ALAIN 发明人 JAQUITH, JAMES, B.;GILLARD, JOHN, W.;LAURENT, ALAIN
分类号 A61K31/40;A61K31/404;A61K31/415;A61K31/4184;A61K31/435;A61K31/437;A61K31/47;A61K31/4709;A61K45/00;A61P25/02;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D209/18;C07D401/14;C07D403/04;C07D403/08;C07D403/14;C07D471/04;C07D471/22;(IPC1-7):C07D403/14;C07D477/00;C07D487/04;C07D487/22 主分类号 A61K31/40
代理机构 代理人
主权项
地址